Foracort Inhaler 200

Description FORACORT INHALER 200 (also known as Foracort-200 Inhaler or Foracort 200 MDI) is a prescription pressurized metered-dose inhaler (pMDI) manufactured by Cipla Ltd. It is a combination maintenance inhaler (not for acute relief) containing: Budesonide IP 200 mcg (inhaled corticosteroid/ICS) Formoterol fumarate dihydrate IP 6 mcg (long-acting beta2-agonist/LABA) per actuation, suspended in propellant HFA 134a. It is supplied as an aerosol inhaler (typically 120 metered doses). The medication is for regular maintenance therapy in asthma and COPD. Patients must keep a separate fast-acting rescue inhaler (e.g., salbutamol) for sudden symptoms. Uses of the Product Foracort Inhaler 200 is indicated for the regular maintenance treatment of: Asthma (in adults and adolescents ≥12 years): Controls symptoms (wheezing, shortness of breath, chest tightness, cough) and prevents exacerbations. It can be used as maintenance therapy (with separate rescue inhaler) or, for the 200 strength, as Single Maintenance and Reliever Therapy (SMART) in appropriate patients. Chronic Obstructive Pulmonary Disease (COPD): Moderate to severe cases with frequent symptoms and history of exacerbations. It improves lung function, reduces symptoms, and lowers exacerbation risk. It is not for acute asthma attacks, status asthmaticus, or sudden worsening. It provides both anti-inflammatory and bronchodilator effects in one device. Side Effects of the Product Side effects are generally mild and local due to the inhaled route. Rinsing the mouth after use reduces many oropharyngeal effects. Common (frequently reported): Oral/pharyngeal candidiasis (fungal thrush in mouth/throat) Hoarseness of voice, sore throat, pharyngolaryngeal pain Headache Cough, upper respiratory tract infection, nasopharyngitis, sinusitis Tremor (shaking of hands/feet) Back pain, body pain, flu-like symptoms Stomach discomfort, nausea, vomiting, diarrhoea Uncommon/rare but important: Palpitations, increased heart rate, chest pain Dizziness, tiredness Pneumonia (increased risk in COPD) Hypokalaemia (low potassium), hyperglycaemia (raised blood sugar) Paradoxical bronchospasm (worsening breathing immediately after use—discontinue and seek help) Long-term/high-dose: adrenal suppression, reduced bone density, eye problems (glaucoma, cataracts, blurred vision), growth effects in children Serious (seek immediate medical help): Allergic reactions (rash, swelling, severe dizziness, breathing difficulty) Severe palpitations, arrhythmias, or signs of overdose (tremor, headache, nausea) Rinse mouth with water and spit after every use to minimize thrush and hoarseness. Report persistent or worsening side effects to your doctor. How to Use the Product Foracort Inhaler 200 is a metered-dose inhaler (MDI). Follow these steps exactly (based on Cipla and standard pMDI instructions): Shake the inhaler well for 5 seconds before each use. Remove the cap. If new or unused for >7 days, prime the inhaler (spray 2–3 test puffs into the air away from face). Breathe out fully (away from the inhaler). Hold the inhaler upright. Place the mouthpiece between your teeth and seal lips tightly (do not bite). Start to breathe in slowly and deeply through the mouth; at the same time, press down firmly on the canister to release one puff. Continue inhaling slowly and deeply. Remove the inhaler from your mouth. Hold your breath for 10 seconds (or as long as comfortable). Breathe out slowly. If a second puff is needed, wait ~30–60 seconds and repeat steps 3–7. Rinse your mouth thoroughly with water (do not swallow) and spit out to prevent thrush/hoarseness. Replace the cap. Clean the mouthpiece weekly with a dry cloth (do not wash in water unless specified). Use at the same times daily. Do not exhale into the inhaler. Technique is critical—ask your doctor/pharmacist to demonstrate. Carry a separate rescue inhaler. Dosage of the Product Dosage is individualized by your doctor based on severity, age, and response. Do not exceed the prescribed dose or use more frequently. For Asthma (maintenance): Adults & adolescents (≥12 years): 1–2 inhalations twice daily (morning and evening). Maximum: 4 inhalations twice daily (under medical supervision). SMART (Single Maintenance and Reliever Therapy) option (for 200 strength only, per doctor): Maintenance 1–2 inhalations daily as-needed puffs for symptoms (max limits apply; reassess if >8–12 total/day). For COPD: 2 inhalations twice daily. Start at the lowest effective dose and titrate down when controlled. Missed dose: take as soon as remembered (unless near next dose—do not double). Overdose symptoms: tremor, palpitations, headache—seek emergency care. How the Product Works (Mechanism of Action – MOA) Foracort Inhaler 200 combines two complementary drugs: Budesonide (ICS): A potent glucocorticoid with high topical anti-inflammatory activity and low systemic absorption. It binds to glucocorticoid receptors, inhibiting inflammatory mediators (cytokines, histamine, leukotrienes), reducing airway swelling, mucus production, and hyper-reactivity. Formoterol (LABA): A selective, long-acting β2-adrenoceptor agonist with rapid onset (1–3 minutes) and 12-hour duration. It stimulates β2-receptors on airway smooth muscle, increasing cAMP, leading to bronchodilation and inhibition of mediator release from mast cells. The combination provides additive/synergistic effects: superior symptom control, better lung function, and fewer exacerbations than either drug alone. Contraindications Hypersensitivity to budesonide, formoterol, HFA 134a, or any excipients (risk of rash, angioedema, anaphylaxis). Primary treatment of status asthmaticus or acute severe asthma/COPD exacerbations (requires intensive measures/other therapy). Use with caution (doctor supervision) in: Active/untreated infections (TB, fungal, viral, bacterial). Cardiovascular disorders (arrhythmias, hypertension, heart failure). Diabetes, thyrotoxicosis, hypokalaemia, seizures, osteoporosis, glaucoma, hepatic impairment. Drug-Drug and Drug-Food Interactions (In Depth) Drug-Drug Interactions (key ones involving budesonide pharmacokinetics or formoterol effects): Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, nelfinavir, atazanavir): Markedly increase systemic budesonide levels (risk of Cushing’s syndrome, adrenal suppression). Avoid or use with extreme caution, dose reduction, and monitoring. Beta-blockers (especially non-selective like propranolol): May antagonize formoterol’s bronchodilation, causing severe bronchospasm. Use cardioselective ones cautiously if essential. QT-prolonging drugs (e.g., quinidine, disopyramide, MAOIs, tricyclic antidepressants, phenothiazines): Increased risk of arrhythmias or prolonged QTc with formoterol. Diuretics (non-potassium-sparing): Formoterol may worsen hypokalaemia and ECG changes. Other LABAs or beta-agonists: Contraindicated (overdose risk—cardiovascular effects, fatalities). Additional: Concurrent short-acting beta-agonists, intranasal steroids, or antihistamines generally safe, but inform your doctor of all medicines. Drug-Food Interactions: No major specific food restrictions. Alcohol: May worsen dizziness or cardiovascular side effects (e.g., palpitations)—consult your doctor. Important Note: This is general information based on the official product monograph and reliable sources. It is not a substitute for professional medical advice. Always read the package insert, follow your doctor’s/pharmacist’s instructions exactly, and consult them for personalized guidance (especially if pregnant, breastfeeding, or with comorbidities). Regular monitoring and correct inhaler technique are essential for safety and efficacy.